Thank you for submitting your manuscript for consideration by The EMBO Journal. I have now had the opportunity to read it carefully and to discuss it with the other members of our editorial team. I am afraid that the outcome of these discussions is not a positive one.
We appreciate that you were able to provide evidence that microbial proteases (S. aureus), either in their purified form or upon release from the bacteria can generate proteolytic fragments of human (met)hemoglobin (either in its purified form or upon release from the red blood cells) in a manner that is enhanced by PAMPs. You were further able to map these Hb fragments and to provide evidence that these fragments contain a high pseudooxidase activity and harbour a PAMP binding site. Furthermore, your data from simulated infection experiments point to the recruitment of catalytically active Hb fragments to bacterial surface (thus to locally restricted activity) and to the release of antioxidants by the red blood cells. These events are then seen to result in an antimicrobial effect. Finally, your data suggest the conservation of such an antimicrobial effect in the horseshoe crab with hemocyanin as respiratory protein. However, it is known that Hb can exert pseudoperoxidase and that hemocyanine can exhibit phenoloxidase activity. Also, an interaction, between Hb and LPS has been reported before. Furthermore, you have published earlier that Hb and hemocyanine can be processed by microbial proteases into highly active, ROS-producing antimicrobial species in a manner that is enhanced by PAMPs. Clearly, we recognise that here, you were able to take this study further and to map the peptides, provide evidence for their recruitment to the microbial surface and to report on an additional release of host antioxidants. So, your present submission does certainly put forward some deeper understanding of the process. Still, we do not feel that it provides an overall conceptual advance that is sufficiently significant to justify publication in The EMBO Journal. We have therefore decided not to send out the paper for in-depth peer review at this point.
Please note that we publish only a small percentage of the many manuscripts that we receive at The EMBO Journal, and that the editors have been instructed to only subject those manuscripts to external review which are likely to receive enthusiastic responses from our reviewers and readers. As in our carefully considered opinion, this is not the case for the present submission, I am afraid, our conclusion regarding its publication here cannot be a positive one.
Thank you in any case for the opportunity to consider this manuscript. I am sorry that we cannot be more positive on this occasion. Re: Appeal for review of manuscript: Manuscript EMBOJ-2009-71616 Title: Rapid reprogramming of hemoglobin structure-function exposes multiple dualantimicrobial potencies
We thank you for recognizing the impact of our findings to some extent, as reflected in your statements of your email of June 18, 2009: "......here, you were able to take this study further and to map the peptides, provide evidence for their recruitment to the microbial surface and to report on an additional release of host antioxidants. So, your present submission does certainly put forward some deeper understanding of the process......" However, we disagree with your decision not to send our manuscript out for review as it appears to be based on the perception that our manuscript does not make you "feel that it provides an overall conceptual advance, ........" May we please offer the following justifications to substantiate our appeal for external review of our manuscript by experts in the field:
(1) We would like to clarify that our paper reports an "anchor-and-attack" mechanism of the Hb. Our findings represent the first elucidation of the underlying mechanism of action of the Hb, which resolves decades of uncertainties and endeavor by scientists to understand how the Hb reacts when outside of the RBC. We showed that the relationship between the microbial protease and PAMPs on the proteolytic activation of hemoglobin (Hb) is more of the coordination between these two virulence factors, rather than enhancement. We showed that PAMPs relax the Hb protein structure to facilitate the cleavages by proteases (Results, page 6, 2nd paragraph; Discussion, page 12 & 13).
(2) We have clearly demonstrated the biological significance of the co-localization of the dualactivities (pseudoperoxidase and PAMP binding) in the activated/released Hb fragments, and have convincingly shown that they elicit a pathogen-targeted attack whilst sparing the host from selfcytotoxicity due to the free radicals generated by the activated Hb (Results, page 7, 2nd paragraph, page 8, 1st paragraph & page 10, 2nd paragraph; Discussion, page 13, lines 17-23).
(3) Although our earlier published work has indeed shown that the invertebrate hemocyanin can also be processed to a quinone-producer for killing the invading microbe, the mechanism of activation is unknown until we demonstrated it in this study. We showed that similar to the Hb, the hemocyanin undergoes an exposure mechanism of the co-localized dual-activities (Results, page 10, 3rd paragraph to page 12, 1st paragraph; Discussion, page 14, 2nd paragraph to page 15, 1st paragraph).
Our focus was not to show that the "ROS-producing antimicrobial activity was enhanced by PAMPs... or re-confirm the activities of Hb-to-pseudoperoxidase, hemocyanin-to-phenoloxidase or Hb-LPS binding". But, the interest and significance of the current manuscript is to show how the host accomplishes this process in a tightly regulated manner elicited by the intrinsic cytotoxic effect of ROS. We showed a counterbalancing effect attributable to the host's own antioxidants which were simultaneously released when the invading microbe hemolyse the host's RBC (Introduction, page 3, 2nd paragraph; Results, page 8, 2nd paragraph; page 17-18; Discussion, page 14, 1st paragraph).
By systematic reconstitution experiments, we have unraveled proteolytically-exposed antimicrobial fragments of the Hb harboring dual-activity centers" -PAMP-binding and ROS catalysis, which would unleash a concurrent "anchor-and-ROS mediated attack" antimicrobial action against the pathogen-in-proximity. We propose that such a mechanism sustains the antimicrobial potency of Hb-ROS while protecting the host from random oxidative toxicity. Thus, this profound mechanism reported in our manuscript is not merely a simple extension of earlier studies, but, for the first time, proposes a novel concept on how the host incisively exploits its respiratory proteins to perform selfdefense and protection without compromising its homeostasis during infection (Introduction, page 4, 2nd paragraph to page 5, 1st paragraph; Discussion, page 14, 1st paragraph).
Our in-depth understanding of the mechanisms underlying how the Hb molecule is promptly transformed into a molecular aggressor against pathogens during blood infection offers useful insights for the development of new therapeutic strategies against life-threatening pathogens of the blood, and create intervention approaches for designing a safer Hb-based blood substitute. Hence, we believe that this manuscript deserves an opportunity of review by experts in the field.
We thank you for your expedient attention and look forward to your generous reconsideration of our manuscript for external review.
Additional Correspondence 02 July 2009
Thank you for your letter asking us to reconsider our decision on your manuscript. In the meantime I have had a chance to consult with an external editorial advisor on your manuscript. We have no objection to seeking advice from referees; but I am sure you appreciate the fact that we cannot predict the outcome of the reviewing process. I will be in touch again as soon as I hear back from the referees. Thank you for submitting your manuscript for consideration by The EMBO Journal. Let me first of all apologise fir the exceptionally long delay in getting back to you with a decision. Unfortunately, one of the referees was not able to return his/her report to us as quickly as initially expected.
Your manuscript has now finally been seen by three referees whose comments to the authors are shown below. As you will see, referees 2 and 3 are positive about the study and would support publication here after adequate revision. In contrast to this positive vote referee 1 raises major concerns regarding the conclusiveness of the data which are in fact rather serious and which in his/her view preclude publication of the study. I should add that the expertise of referee 1 and the other two referees is different which could explain the rather different overall assessment of the manuscript. Clearly, referees 2 and 3 consider the study as very interesting in principle and the concerns of referee 1 are of technical nature. We have therefore come to the conclusion that we could give you the chance to address the referees' criticisms in a revised manuscript, However, it will be indispensable to address the severe concerns raised by referee 1 in an adequate manner and beyond any doubt. If you feel that you can fulfil these requirements and if you thus submit a new version of this manuscript we will need to re-evaluate this issue in depth which may mean that in addition to referee 1 we will have to involve a new referee, an additional expert with the right expertise to assess the concerns raised by referee 1 and your response to them. Only if the outcome of such further consultation with an additional expert is a positive one we will be able to come to a positive final decision.
I should remind you that it is EMBO Journal policy to allow a single round of revision only and that, therefore, acceptance or rejection of the manuscript will depend on the completeness of your responses included in the next, final version of the manuscript as well as on the final assessment by an additional expert.
Thank you for the opportunity to consider your work for publication.
Yours sincerely,
Editor
The EMBO Journal
Referee #1 (Remarks to the Author):
In this manuscript the authors describe a new antimicrobial property of human Hb where multiple fragments are released from the molecule when it gets in direct contact with microbes. Two of these fragments have a microbe-binding and pseudoperoxidase activities that result in a "shock killing" of the pathogen in proximity due to a bust of oxygen free radicals (ROS) by Hb. The host on the other hand protects its self by releasing its own endogenous antioxidants. The authors make the claim that this duel action centers may be applied in the design of safe and effective Hb-based blood substitutes.
This work contains a number of claims that are not substantiated experimentally. A case in point is that these authors truly misrepresent one of Hb "enzymatic" activities i.e. the so called pseudoperoxidase activity. Moreover, they did not use appropriate experimental tools to show that these reactions occur and are indeed responsible for Hb's action.
The pseudoperoxidase results from the reaction of Hb with hydrogen peroxide resulting in complex redox chemical reactions. First peroxide oxidizes ferrous Hb to generate the higher oxidation state of the protein, the ferryl Hb and then peroxide reacts with ferric Hb, resulting in a ferryl protein radical. It is this radical chemistry that drives the subsequent heme-cross links (diagnostic for damage and prooxidative) rather than generic ROS as these authors claim to have occurred and subsequently measured using the so called CL-CLA assay.
Authors need to actually measure these Hb oxidative intermediates and their associated radicals (photometric, HPLC and EPR) and correlate these measurements with toxicity or the lack of it when these elements are recycled back, see for example (D'Agnillo F., Blood 98:3315, 2000; Reeder BJ., Curr Med Chem. 12:2741 , 2005 As for the mass spectrometry measurements: 1. All of the protein identifications by mass spectrometry should include Mascot identity scores and the cutoff value.
2. The data in supplementary figure S2 shows identification for Hb beta-F4 with only two masses.
There should be at least three masses for a good identification by PMF. In lieu of this the protein coverage by amino acid content should be provided and the Mascot identity scores that is associated with this spectrum.
3. The mass spectrometry data that supports supplemental figure S4B does not appear to be present. If the information is provided somewhere in the manuscript it's location should be indicated in the figure caption. If the information is not in the manuscript then it should be provided.
Referee #2 (Remarks to the Author):
This paper by Ding and colleagues is a continuation of their earlier study (published in Nature Immunology 2007) on the pseudoperoxidase or phenoloxidase activity and antimicrobial function of mammalian hemoglobin or the horseshoe crab hemocyanin, respectively. In the present work the authors demonstrate that hemoglobin (as well as hemocyanin) is proteolytically cleaved by bacterial or fungal proteases and that the resulting fragments are capable to bind pathogen-associated microbial patterns (PAMPs) and to exhibit pseudoperoxidase (POX) and phenoloxidase (HMC-PO) activity, which leads to the formation of reactive oxygen intermediates (ROI) and contributes to the killing of ROI-sensitive bacteria. The authors also provide evidence that microbial proteases and PAMPs cooperate in catalyzing the ROI-generating function of hemoglobin. Finally, they show that in a more physiological setting, where hemolytic bacteria (Staphylococcus aureus, expressing the V8 protease) and red bood cells (RBC)are coincubated, the Hb-dependent generation of ROI is accompanied by the release of antioxidants (catalase, superoxid dismutase)following the lysis of the RBC, which help to limit the generation of ROI and to restrict their action to the infection site. The authors conclude that their data support an "anchor-and-ROI-attack" mechanism, which is based on the dual-action centers of the hemoglobin fragments (i.e.microbial binding and ROI formation).
General comments:
This study contains a series of thoroughly performed and complete experiments, the results of which are entirely in accordance with the model proposed by the authors. A major strength of the work is the application of a broad spectrum of techniques ranging from cell biological methods to mass spectrometry and electron microscopy as well as the intriguing bridge between the mammalian and invertebrate system. Needless to say that the topic per se (antimicrobial activity of respiratory proteins)is of fundamental relevance for immunologists, but certainly also for physiologists and cell biologists.
I have only three points of criticism which require careful attention by the authors: 1. The proposed synergism between PAMPs and microbial proteases (elastase, subtilisin A)is readily visible on the level of methemoglobin proteolysis, but virtually absent on the level of POX activity (see Fig. 1D ). The authors somewhat ignore this by simply stating that despite increased methemoglobin proteolysis in the presence of proteases plus PAMPs the POX activity is maintained.
On the other hand they argue that the binding of PAMPs alleviates the proteolysis and that the proteolysis is a prerequisite for POX activity. The authors need to clarify this discrepancy in argumentation as well as their overall hypothesis. 2. Figure 3 : The simulated infection experiment is not quite clear. In the Material and Method section the authors state that proteases (V8) produced by the bacterial culture at increasing doses were added (2.5, 5.0 and 7.5 units). In the legend to Figure 3 they state that 1x denotes 2.5 units of V8 protease produced by 1.8 x 10^7 CFU of S. aureus. This reviewers wonders how the authors will be able to determine the exact amount of V8 protease produced by S. aureus in the infection experiment. Please clarify. 3. As part of their overall concept and hypothesis the authors postulate that the production of ROI is mitigated by catalase and superoxide dismutase released by lysed red blood cells and by the bacteria themselves. Whereas the addition of exogenous catalase and SOD is certainly acting in the proposed manner, the experiment meant to demonstrate that endogenously released catalase and SOD are indeed limting the release of ROI has to be interpreted with more caution, because diethyldithiocarbamate (DDC) and 3-amino-1,2,4-triazole (3AT; wrongly termined trizole in the paper) are not really specific inhibitors. DDC binds divalent cations and therefore not only blocks SOD, but any other divalent cation-dependent enzyme, and the triazole, for example, is also a known inhibitor of NO synthase (the latter is not present in erythrocytes, but NO activity was described in several bacterial species). Thus, the inhibitor data fit with the hypothesis, but alternative mechanisms are not excluded.
Referee #3 (Remarks to the Author):
The manuscript by Du et al provides convincing evidence of the antimicrobial activity of haemoglobin released from red blood cells. The data presented in this manuscript is strong and self supporting. The concept introduced in this manuscript is highly novel. There are a number of points that I recommend the authors address in order to improve this manuscript.
1. The English usage of this manuscript could be further improved. I felt that the Abstract, Introduction and last paragraph of the Discussion are over-embellished, and could be simplified and use less "expressive" terminology. I believe that this could be addressed by an experienced copy editor.
2. The authors employ the isogenic knock-outs of V8 and elastase genes in this work. A fundamental prerequisite of molecular microbiology is to fulfill Koch's molecular postulates in the use of isogenic mutants. This requires the use of a complemented mutant (eg. V8 or elastase mutant where the wildtype gene is re-introduced into the mutant background). A complemented mutant must be used to demonstrate that the re-introduction of the intact gene restores the phenotype. This is a critical control that is missing from these experiments and must be included.
3. The authors have used an artificial blood mix to demonstrate bacterial killing. Would it have been possible to undertake the same experiments as described in Figure 3 and Figure 4 to mimic the most biologically significant environment.
4. Bacterial killing is expressed in terms of percent killing in Figure 3 -5. In examining antimicrobial activity is is more usual to express bacterial killing using a log scale, in order to easily demonstrate the effect of any treatment. A fall in bacterial numbers from 10*7 to 10*6 is impressive, but shows only a 1 log reduction in bacterial numbers.
5. The authors suggest that activated Hb contains specific PAMP-binding sites. There is indirect evidence for this provided by the authors. However, it would be possible to demonstrate specificity by either by showing that an isogenic mutant lacking the receptor (LTA, LPS) is protected from killing. Alternatively, the use of antibodies specific for LTA or LPS would block binding, and hence killing, by activated Hb. This type of experiment would demonstrate that these bacterial components are the specific targets of activated Hb.
6. In my view the discussion of this manuscript is too long, and could be shortened by 1/3 without losing any meaning or significance.
Minor points:
1. Use the term "virulence determinants" not "virulent determinants" throughout.
2. The last sentence of page 9 refers to Figure 1C not Figure 1D ? (D'Agnillo F., Blood 98:3315, 2000; Reeder BJ., Curr Med Chem. 12:2741 , 2005 .
Authors' Response: We thank the reviewer for useful comments and suggestions. It is indeed notable that the 'pseudoperoxidase (POX)' cycle occurs during oxidation and conversion of HbFe III (metHb) HbFe IV (ferryl-Hb), a process which eliminates the H 2 O 2 in a peroxidase-like manner and where the ferryl-Hb and protonated superoxide radicals are generated simultaneously (Alayash, 1999; Cashon & Alayash, 1995) . To clarify and eliminate any potential confusion, we have revised the term 'POX' to 'POX cycle'. Furthermore, a more defined term, 'ferryl-Hb protein radical and protonated superoxide radical' has been used to replace the 'reactive oxygen species (ROS)', and subsequently this was referred as free radicals, produced by the Hb. We have also clarified several definitions in the Introduction (page 3, 1st paragraph).
The chemiluminescent Cypridina luciferin analog (CLA) is a very specific extensively utilized substrate for the detection of superoxide (Ito et al, 2001; Kawano et al, 2002; Kimura et al, 1995; Nakano, 1990; Nakano et al, 1986) . Hence, the Cypridina luciferin analog-chemiluminescence assay (CLA-CL assay) is specific for determining the production of superoxide during the oxidation of HbFeIII HbFeIV. Since the production of ferryl-Hb is accompanied by the generation of protonated superoxide, and the CLA-CL assay is sensitive and specific for tracking the instant release of superoxide (when Hb is exposed to H2O2), we believe it is appropriate to use the CLA-CL assay to measure the free radicals produced, and represent the instant activation of Hb-POX cycle activity.
According to the suggestion of this reviewer, in order to unequivocally show the formation of Hb intermediates during oxidation and production of the associated radicals, we have monitored the absorption spectral changes of Hb spectrophotometrically between 500 ñ 700 nm (Giulivi & Davies, 1994; Winterbourn, 1990) ; and the Hb intermediates and its associated radicals of concern in this study were determined biochemically and empirically, for example, (a) for the reaction with metHb (HbFeIII), the spectral changes of metHb, and the formation of ferryl-Hb and superoxide radicals were determined and (b) for the reaction with Hb-from-RBC or Hb-in-blood (HbFeII), the spectral changes of Hb, the formation of metHb, ferryl-Hb and superoxide radicals were measured. These new results showed that upon encounter of H2O2, there was an instant surge of the characteristic peaks of ferryl-Hb (HbFeIV) intermediate from the microbial protease-treated metHb (see Supplementary Figure S1 ), and ferryl-Hb (HbFeIV) & metHb (HbFeIII) intermediates in the bacterial protease-treated Hb-from-RBC or Hb-in-blood (see Supplementary Figure S3 ). The appearance of these Hb intermediates was accompanied by the formation of ferryl-Hb and superoxide radicals (see Figures 1, 3 & 4) . Thus, these results affirm the proteolysis-induced rapid oxidation of Hb to activate its POX cycle activity, which concomitantly resulted in the production of higher levels of free radicals when exposed to H2O2. All these data have been incorporated into Figures 1, 3 & 4 and Supplementary Figures S1 and S3 , respectively, in the revised manuscript.
Since this study focused on the proteolytic activation of Hb by the microbial proteases, the proteolysed and non-proteolysed Hb were included in the analysis of the formation of Hb intermediates and associated radicals in order to compare the cytotoxicity induced by the free radicals generated. Our results showed that only microbial-protease proteolysed Hb underwent rapid oxidation to produce higher levels of free radicals, which subsequently caused significant microbicidal activity as compared to that of the non-proteolysed Hb (see Figure 3 and Supplementary Figure S3) . 
As for the mass spectrometry measurements: 1. All of the protein identifications by mass spectrometry should include Mascot identity scores and the cutoff value.

The data in supplementary figure S2 shows identification for Hb beta-F4 with only two masses. There should be at least three masses for a good identification by PMF. In lieu of this the protein coverage by amino acid content should be provided and the Mascot identity scores that is associated with this spectrum.
Authors' Response: The masses of three peptides identified for the Hb beta-F4 and the Mascot scores associated with the respective mass spectra are now included in the revised manuscript (see Supplementary Figure S2B ).
The mass spectrometry data that supports supplemental figure S4B does not appear to be present. If the information is provided somewhere in the manuscript it's location should be indicated in the figure caption. If the information is not in the manuscript then it should be provided.
Authors' Response: The mass spectra data including the peptides identified, and the Mascot scores are now incorporated into the revised manuscript (see Supplementary Figure S5C ). Fig. 1D )
Referee #2 (Remarks to the Author):
This paper by Ding and colleagues is a continuation of their earlier study (published in Nature Immunology 2007) on the pseudoperoxidase or phenoloxidase activity and antimicrobial function of mammalian hemoglobin or the horseshoe crab hemocyanin, respectively. In the present work the authors demonstrate that hemoglobin (as well as hemocyanin) is proteolytically cleaved by bacterial or fungal proteases and that the resulting fragments are capable to bind pathogen-associated microbial patterns (PAMPs) and to exhibit pseudoperoxidase (POX) and phenoloxidase (HMC-PO) activity, which leads to the formation of reactive oxygen intermediates (ROI) and contributes to the killing of ROI-sensitive bacteria. The authors also provide evidence that microbial proteases and
. The authors somewhat ignore this by simply stating that despite increased methemoglobin proteolysis in the presence of proteases plus PAMPs the POX activity is maintained. On the other hand they argue that the binding of PAMPs alleviates the proteolysis and that the proteolysis is a prerequisite for POX activity. The authors need to clarify this discrepancy in argumentation as well as their overall hypothesis.
Authors' Response: We thank the reviewer for alerting us to the concerted action of PAMPs and proteases on the proteolytic activation of the Hb. The discrepancy has been clarified in the revised manuscript (see Results, page 7, 2nd paragraph and Discussion, page 16, 1st paragraph).
The levels of POX cycle activities as shown by the CLA-CL assay, are not totally absent but slightly reduced when Hb was reacted with both PAMPs and microbial proteases (LPS & elastase, LTA & subtilisin A) (see Fig 1D, highlighted in red boxes) . Therefore, we amended the statement to read as follows: 'Furthermore, such greater proteolysis of metHb in the presence of higher level of PAMPs ( Figure 1D ,  ) was found to correlate with marginal reductions in the POX cycle activities ( Figure  1D , *), indicating that either further cleavages of active POX-bearing fragments have occurred, or there was blockage of substrate entry due to the accumulated PAMPs bound.' (see page 7, 2nd paragraph in the revised manuscript). However, until further evidence is forthcoming, we admit that at this juncture, we can only speculate/envisage the further cleavage of POX cycle active fragments, thus, we have toned down our claim to read as follows: 'The accumulation of PAMPs bound to the Hb fragments could in turn cause steric hindrance to the entry of substrates, resulting in a negative feedback regulation to prevent excessive POX cycle activity.' (see Discussion, page 16, 1st paragraph). (2.5, 5.0 and 7.5 
Figure 3: The simulated infection experiment is not quite clear. In the Material and Method section the authors state that proteases (V8) produced by the bacterial culture at increasing doses were added
units). In the legend to Figure 3 they state that 1x denotes 2.5 units of V8 protease produced by 1.8 x 10^7 CFU of S. aureus. This reviewers wonders how the authors will be able to determine the exact amount of V8 protease produced by S. aureus in the infection experiment. Please clarify.
Authors' Response: For the simulated infection experiment, we used V8 protease that was natively produced by the V8+ S. aureus. The V8 protease activity in the V8+ S. aureus culture was determined (in Units) by azocasein assay, which was described in the Supplementary methods, page 5, 2nd paragraph (revised manuscript). The number of viable bacteria count (in CFU) contained in this V8+ S. aureus culture was enumerated by using the spread plate method via serial dilutions. This clarification is now incorporated into the revised manuscript (see Materials and Methods, page 20, 3rd paragraph to page 21 1st paragraph, and legend to Figure 3 , page 24). Authors' Response: We thank the reviewer for advice on the specificity of the antioxidant inhibitors, and their effect on the activated Hb free radicals production.
As part of their overall concept and hypothesis the authors postulate that the production of ROI is
The full name of 3AT has been amended to 3-amino-1,2,4 triazole in the revised manuscript. Although 3AT could have inhibitory effect on the NO synthase, firstly, we could not, to the best of our ability, find any direct evidence for its inhibition of the NO synthase in the S. aureus used in this study; secondly, as negative controls for Figure 4D , the viability of the bacteria, at 93 -107%  appeared unaffected when incubated with 3AT alone or 3AT & H2O2, indicating that 3AT mainly targets the catalase in this study.
We agree that diethyldithiocarbamate (DDC) is a copper-chelating agent which binds to divalent cation. Besides inhibiting the activity of SOD, the DDC could also deplete reduced glutathione, a native antioxidant, according to Kelner & Alexander (1986) . Hence, we have further examined the ratio of the resulting GSH:GSSG in the reaction with or without DDC (0.1 mM, 0.5 mM), with a view to studying the effects of this natural antioxidant on the generated Hb free radicals. Our results showed that the ratio of GSH:GSSG was decreased dose-dependently of DDC (see Supplementary  Figure S3E ), indicating that DDC inhibits both SOD and GSH antioxidants. Thus, it supports our postulation that the antioxidant released by the hemolysed RBC serves to downplay the cytotoxicity of free radicals, which could otherwise be detrimental to the host as well. This new finding has been incorporated into the revised manuscript (see Results, page 11, 2nd paragraph Authors' Response: We agree that a complemented mutant is an important method to study and verify the phenotype encoded by a specific gene. However, the main aim of this study (in employing the protease isogenic knock-out strain) was to compare the proteolysed & non-proteolysed Hb/HMC and the consequence of the induced cytotoxicity due to the production of free radicals. Hence, our use of protease +/-bacterial stains to induce the proteolysis/non-proteolysis of the Hb/HMC proteins was necessary and sufficient to achieve the goal, particularly we have shown the dose-dependent effect.
mutants of both the P. aeruginosa and S. aureus could become an important future perspective. Nevertheless, following from this reviewer's suggestion, in (in revision of this manuscript), we have attempted two new experiments: (i) flow cytometric analysis of the binding of activated Hb fragments to bacteria with and without treatment with anti-LPS /anti-LTA antibodies and (ii) bacterial killing assay by the activated Hb fragments in the presence/absence of anti-LPS /anti-LTA antibodies .
To perform the above experiments, we have exhaustively searched worldwide for commercially available and reliable anti-LPS that could be specific against P. aeruginosa and anti-LTA against S. aureus, but to no avail. Still, we finally purchased the anti-E.coli LPS, which was claimed to crossreact with P. aeruginosa (Lifespan Biosciences, LS-C83086) and Gram Positive Bacteria Marker 15711, which cross-reacts with S. aureus LTA (Santa Cruz, . Using these antibodies, we performed flow cytometric analysis after pre-incubating the bacteria with the respective antibodies (as shown in the Referee only Supplementary Figure attached) . It shows only slight reduction in the binding of Hb fragments to P. aeruginosa or S. aureus, after both bacteria were pre-incubated with anti-E. coli LPS and Gram Positive Bacterial Marker 15711, respectively. This could either be due (i) to the lack of specificity of the anti-LPS/-LTA antibodies against the respective bacterial PAMPs, thus the inefficient blocking of the LPS/LTA; or (ii) the well-known notoriety of such antibodies to fail to recognize the PAMPs since the LPS/LTA tends to form heterogenous micelles with structural variations and diversity, which could encrypt the antigenic epitopes (Dixon & Darveau, 2005; Pier, 2003; Pollack et al, 1989; Warren et al, 1993 ).
Notwithstanding the above observation of the apparent lack of specific binding of the antibodies to the bacteria, we tested the effect of the antibodies (0.1 and 1 µg/ml) on the bacterial killing induced by the Hb fragments. However, we found that the antibodies themselves had adverse effect on the bacteria. The anti-LPS antibody killed 20-30% of the P. aeruginosa bacteria even in the absence of Hb fragments. On the other hand, the Gram Positive Bacteria Marker 15711 antibody promoted the growth of S. aureus by 20-60%, indicating that these antibodies are probably unsuitable for binding and blocking of the PAMPs /protection of the bacteria from the activated Hb fragments.
Having attempted the above-described experiments, we wish to re-iterate that our initial procurement of the Hb-POX active fragments was based on the specific pull-down experiment in which we used PAMP-Sepharose (see Figure 2) . Therefore, it is reasonable to expect the presence of PAMP-binding sites on these pulled-down Hb fragments. Furthermore, the control experiment using Sepharose alone did not pull down any Hb fragments. Besides, the binding of Hb to LPS has been well studied and reported before (Currell & Levin, 2002; Howe et al, 2007; Jurgens et al, 2001; Kaca et al, 1994; Roth et al, 1994) . In addition, we have shown a strong binding affinity (nM) between the proteolytically activated Hb fragments and LPS by Surface Plasmon Resonance analysis (unpublished data). Hence, our hypothesis of Hb fragments with LPS-binding sites is appropriate and evidently supported. Thank you for sending us your revised manuscript. Our original referees 1 and 3 have now seen it again, and you will be pleased to learn that in their view you have addressed their criticisms in a satisfactory manner.
Still, there is one remaining editorial issue that needs further attention.
Prior to acceptance of every paper we perform a final check for figures containing lanes of gels that are assembled from cropped lanes. While cropping and pasting may be considered acceptable practices in some cases (please see Rossner and Yamada, JCB 166, 11-15, 2004 ) there needs to be a proper indication in all cases where such processing has been performed according to our editorial policies. Please note that it is our standard procedure when images appear like they have been pasted together without proper indication (like a white space or a black line between) to ask for the original scans (for our records).
In the case of the present submission there are a number of panels that do not appear to fully meet these requirements: figure 1B, Figure 1D I therefore like to kindly ask you to send us a new version of the manuscript that contains suitably amended versions of these figures. I feel that it would also be important to explain the assembly procedure for these figures (i.e. that all lanes come from the same gel) in the figure legends. In respect to figure 1D (right panel) I would like to point out that the presentation of the data needs to be adjusted in a way that in each case the full lane is shown and I need to ask you to replace the panel either with the full original gel or by a replicate experiment. Please be reminded that according to our editorial policies we also need to see the original scans for the figures in question.
I am sorry to have to be insistent on this at this late stage. However, we feel that it is in your as well as in the interest of our readers to present high quality figures in the final print version of the paper.
Thank you very much for your cooperation.
Editor
REFEREE REPORTS: ------------------------------------------------
none Referee #3 (Remarks to the Author):
In my opinion, the authors have faithfully and dilligently addressed the reviewers various concerns, and I belive this manuscipt is suitable for publication in EMBO Journal. We thank you and the reviewers for the constructive comments and suggestions to improve the manuscript, and we are very happy to note the positive outcome from the reviewers. To further address the editorial concerns on Figure 1B and 1D, we have replaced these two SDS-PAGE gel images with the original ones showing the entire length of all the lanes. The following points regarding the preparation of these revised Figures are provided for your kind reference: -All the lanes in the SDS-PAGE image presented in Figure 1B , left panel were from the same gel. The earlier image only showed the cropped lanes taken from one of the duplicate lanes of each sample. We have now replaced the figure with the original image, which also shows the entire length of each lane, and clearly annotated the lanes accordingly. -In Figure 1B , right panel, the '1st SDS-PAGE' refers to the first dimensional separation of proteins on one SDS-PAGE, following which we excised the whole gel lane and overlaid it on the '2nd Tris-Tricine SDS-PAGE' for the second dimensional resolution of each band of proteins. For clarity, we have framed the 1st SDS-PAGE lane to indicate it was from one gel for the1st separation before the 2nd separation, which was performed on the 2nd gel. -
The earlier Figure 1D already showed the original gel images but with cropped regions, which we initially thought were of relevance to this study. However, we have now also replaced it with the original gel images showing the entire length of the lanes. We thank you for your suggestions and believe that these figure amendments meet the requirements of the EMBO J. We greatly appreciate your expedient attention and the reviewers' time. We look forward to hearing a favorable reply from you at your earliest convenience. Thank you for sending us an amended version of your manuscript, including an amended figure 1. I have now had a chance to look into the matter, however I feel that there is still a major issue with one of the panels, figure 1D right panel. In the 3rd lane from the right (5th lane from the left) the lane is not continuous and the upper band does not appear to come from this lane. This can be seen at higher magnification. This issue needs to be sorted out in an adequate manner. I therefore need to ask you to replace the panel either with the full original gel or by a replicate experiment. In any case we need to ask you for the original scan for this panel for our records.
Editor
The EMBO Journal We thank you for your patience and sincerely apologize for any inconvenience caused. We have now repeated the experiment and replaced the Figure 1D , right panel with a new gel image. The original scanned image in TIFF is also included as a separate file for your editorial record.
Again, we greatly appreciate your expedient attention and believe that this figure amendment should meet the requirements of the EMBO J.
We look forward to hearing a favorable reply from you at your earliest convenience. Figure 1D right panel original scan:
